DASATINIB

Generic: DASATINIB

Teva PharmaceuticalsManufacturer
ORALRoute
DASATINIBActive Substance
2025-08-27Original Approval

DASATINIB is FDA application ANDA211094, sponsored by TEVA PHARMS USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
PLEURAL EFFUSION
1,186 reports
2
DRUG INEFFECTIVE
712 reports
3
DRUG INTOLERANCE
555 reports
4
DRUG RESISTANCE
533 reports
5
DEATH
458 reports
6
DIARRHOEA
438 reports
7
THROMBOCYTOPENIA
425 reports
8
DYSPNOEA
409 reports
9
MALIGNANT NEOPLASM PROGRESSION
391 reports
10
FATIGUE
375 reports